Table 3. Proportion of patients with pedal edema at follow-up.

Patients with pedal edema (n=88) at baseline visit are excluded from the analysis of the incidence of pedal edema.

CI: confidence interval.

Parameter	Category	Overall (N = 10,106), n (%)	95% CI for the proportion
Patients with pedal edema	Amlodipine (n=2,430)	31 (1.28%)	(0.83; 1.72)
	Amlodipine+Atenolol (n=476)	8 (1.68%)	(0.53; 2.84)
	Amlodipine+Bisoprolol (n=638)	4 (0.63%)	(0.01; 1.24)
	Amlodipine+Chlorthalidone+Telmisartan (n=424)	3 (0.71%)	(-0.09; 1.51)
	Amlodipine+Hydrochlorothiazide+Olmesartan (n=425)	3 (0.71%)	(-0.09; 1.5)
	Amlodipine+Hydrochlorothiazide+Telmisartan (n=1538)	8 (0.52%)	(0.16; 0.88)
	Amlodipine+Metoprolol (n=1340)	15 (1.12%)	(0.56; 1.68)
	Amlodipine+Telmisartan (n=2835)	20 (0.71%)	(0.4; 1.01)